InsightsChange & Innovation

For 40 years, every change program opened with the same question: "What's broken?"

By Uttam Dinodia1 min readView this post on LinkedIn

David Cooperrider argues that the question is exactly why 70% of them collapse.

Not the leadership. Not the communication. Not the resistance, McKinsey loves to blame the question itself.

Cooperrider built the Appreciative Inquiry framework on one idea:

Organisations grow in the direction of what they study.

Study failure, and people rehearse failure. Study what gives life, and that pattern multiplies.

The framework runs in 4 phases:
1 → Discovery: where is this system most alive
2 → Dream: what could it become
3 → Design: what structures support that
4 → Destiny: how do we sustain momentum

The proof came at GTE (now Verizon) in 1996.

President Tom White led the entire change program using Appreciative Inquiry rather than problem-solving. 14 months later, GTE won the 1997 ASTD award for best organisational change program in the country. Stock, morale, customer relations, union-management trust: all of it moved.

White's line is the part most strategy decks miss:

"We concentrate enormous resources on correcting problems that have a relatively minor impact on overall performance."
But here is the part Cooperrider's followers undercite: even McKinsey warns that excessive positivity leads to watered-down aspirations.

So the lesson is not that diagnosis is wrong.
Diagnosis without inquiry into strength produces fatigue, not change.

If your last three planning meetings opened with "what is failing," try one that opens with "where are we already winning, and why."

You will not get the same answers.

Which opening question does your team default to: "what's broken" or "what's working"? Curious what's worked in your experience.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.